Urodele amphibians can regenerate amputated limbs. It has been considered that differentiated dermal tissues generate multipotent and undifferentiated cells called blastema cells during limb regeneration. In early phases of limb regeneration, blastema cells are induced by nerves and the apical epithelial cap (AEC). We had previously investigated the role of neurotrophic factors in blastema or blastema-like formation consisting of Prrx-1 positive cells. A new system suitable for investigating early phases of limb regeneration, called the accessory limb model (ALM), was recently developed. In this study, we performed a comparative transcriptome analysis between a blastema and wound using ALM. Matrix metalloproteinase (MMP) and fibroblast growth factor (FGF) signaling components were observed to be predominantly expressed in ALM blastema cells. Furthermore, we found that MMP activity induced a blastema marker gene, Prrx-1, in vitro, and FGF signaling pathways worked in coordination to maintain Prrx-1 expression and ALM blastema formation. Furthermore, we demonstrated that these two activities were sufficient to induce an ALM blastema in the absence of a nerve in vivo.
Introduction
Urodele amphibians can regenerate some lost body parts such as limbs. An amputated limb results in the formation of a regeneration blastema, which comprises undifferentiated cells known as blastema cells. The regeneration blastema cells were considered as a homogeneous, undifferentiated cell population; however, recent cell fate tracing experiments have shown that they are a heterogeneous cell population (Hirata et al., 2010; Kragl et al., 2009) . Some blastema cells derived from muscles remain unipotent. Some blastema cells derived from dermal tissues can redifferentiate into varied cell type within the connective tissue lineage during limb regeneration. Induction of such blastema cells is unique and important in understanding limb regeneration.
An amputation model would not be appropriate for studying early events in limb regeneration because amputation causes many simultaneous reactions in the same area. It is suggested that limb regeneration triggered by amputation initiates at least two distinct regenerations to restore missing parts (Satoh et al., 2010b) . Regeneration of distal structures is dependent on the apical epithelial cap (AEC), which is the blastema epithelium, whereas regeneration of a proximal structure is independent from the AEC. These two types of regenerations exhibit distinct gene expression pattern (Satoh et al., 2010b) . Furthermore, histolysis and anti-inflammatory responses also occur after an amputation. Such complex processes make early phases of limb regeneration difficult to study. A new experimental system called the accessory limb model (ALM) was recently developed (Endo et al., 2004; Satoh et al., 2009 ). This model is based on the results/ insights obtained from previous studies (Egar, 1988; Lheureux, 1977; Maden and Mustafa, 1984) . ALM has two advantages: (1) it can generate a completely patterned limb by only damage in skin and nerves. In other words, limb regeneration can be studied using only these two tissues. (2) ALM is a simpler system for examining early regeneration reactions than the amputated limb model. A regenerate using ALM is formed in a single regeneration system, which is called the AEC-dependent regeneration (Satoh et al., 2010b) . A regeneration blastema in ALM seems not to contain AEC-independent regeneration in contrast to a blastema in an amputated limb. Furthermore, less damage is required to induce limb regeneration, minimizing histolysis. These advantages of ALM make the study of limb regeneration much simpler. In the early phases of ALM, a deviated nerve is covered by a migrating epithelium called wound epithelium/epidermis (WE). WE covers the nerve within several hours (Ferris et al., 2010; Satoh et al., 2008b; Yang et al., 1999) . After the WE migration, nerves and the WE come in contact with each other. The epithelium overlying the axon ends is specified as AEC and is necessary for limb regeneration (Satoh et al., 2008b) . In the presence of AEC and a nerve, fibroblasts can Developmental Biology 355 (2011) 263-274 become blastema cells (Satoh et al., 2008a) . Without the nerve, neither AEC nor blastema formation is possible; instead, the wound heals. After blastema cells are induced, they are thought to undergo redevelopment to complete limb regeneration Gardiner et al., 2002) . During redevelopment, blastema cells derived from dermal fibroblasts can differentiate into various cell types, including cartilage (Hirata et al., 2010; Kragl et al., 2009; Muneoka et al., 1986) . However, the mechanism by which such multipotent blastema cells are induced remains unknown. Fibroblast activation to become a blastema cell is believed to take place at nearly the same time as AEC induction. Actually, at the very beginning of limb regeneration, nerve involvement, AEC induction, and fibroblast activation take place almost simultaneously and in the same area. Therefore, an inclusive understanding of these three processes is required, and ALM is the best model for studying the early phases of limb regeneration.
Several developmental genes are re-expressed in a regeneration blastema, as in a developing limb bud. An apical epidermal ridge (AER) is formed at the distal region of a developing limb bud in higher vertebrates, and is considered equivalent to AEC. Furthermore, genes expressed in AEC are also expressed in AER. Sp-9 is an AEC/AER marker gene (Kawakami et al., 2004; Satoh et al., 2008b) and is expressed in the basal layer of the distal blastema epithelium, where Fgf-8 and fibronectin are also expressed (Critchlow and Hinchliffe, 1994; Han et al., 2001; Nace and Tassava, 1995) . In addition, developmental genes are reexpressed in blastema mesenchymal cells as well as AEC. For example, Hoxa-13, which is an autopod marker in many vertebrates, is expressed in the distal region of the blastema (Gardiner et al., 1995; Tamura et al., 2008; Zakany and Duboule, 2007) . Meis genes are regulated in the proximal region of the blastema, as in the developing limb bud of other vertebrates (Capdevila et al., 1999; Mercader et al., 1999 Mercader et al., , 2005 . Such spatiotemporal gene expression patterns strongly suggest that the blastema is similar in structure to a developing limb bud. However, limb bud cells are derived from undifferentiated tissue, such as the lateral plate mesoderm, while blastema cells are considered to be derived from fully differentiated tissues. Therefore, at the very beginning of limb regeneration, an amputated limb should generate undifferentiated blastema cells from differentiated cells/tissues. This process is called "dedifferentiation." This dedifferentiation appears to be unique and differs from limb development. Redevelopment begins after blastema formation . Although it is still uncertain whether later phases of limb regeneration are completely identical to limb development, studies of limb development have helped us understand the later phases of limb regeneration. However, because of the unique nature of the early phases of limb regeneration, there is no choice but to investigate early phases of limb regeneration. In order to reveal how urodele amphibians generate blastema cells in the early phase, we focused on the fibroblast activation in dedifferentiation phase. A potential marker gene, Prrx-1 (Phox-1, Prx-1, Pmx-1), is expressed throughout the developing limb bud mesenchyme, and its promoter region has been used in some transgenic lines to deliver transgenes to the limb mesenchyme (Kuratani et al., 1994; Leussink et al., 1995; Martin and Olson, 2000; Nohno et al., 1993) . Recently, Prrx-1 expression pattern, detected from very early stages, was reported in urodele and anuran limb regeneration Suzuki et al., 2007) . As mentioned above, blastema cells derived from dermal fibroblasts show multipotency within a connective tissue lineage. Prrx-1 is expressed in multipotent blastema cells but is not detectable by in situ hybridization in fully differentiated fibroblasts; therefore, Prrx-1 is considered to be an ideal marker gene for tracing dermal fibroblast activation in the early phase of limb regeneration.
We investigated Prrx-1 reactivation using ALM. To gain an integrated understanding of the early events involved in blastema formation, we performed a comparative transcriptome analysis of blastema and lateral skin wounds using ALM. In this analysis, two gene groups were selected, Fgf signaling components and MMPs. Both have been suggested to be important regulators of limb regeneration. FGF1 and 2 have been identified as nerve trophic factors (Dungan et al., 2002; Mullen et al., 1996) . FGF8 is well known as an AEC factor in amphibians Han et al., 2001 ). Fgf-10, which is expressed in the limb mesenchyme, is a counterpart of Fgf-8. Disappearance of Fgf-10 expression in limb bud mesenchyme is correlated with a loss of limb bud regeneration capability in Xenopus laevis (Yokoyama et al., 2000) . MMPs are a necessary component of limb regeneration (Vinarsky et al., 2005) , and their role in regeneration is still under debate. We found that these Fgf signaling components and MMPs were predominantly expressed in ALM at higher levels than in regular wound. Fgf signaling was necessary for the maintenance of a blastema but not for the induction of a blastema marker gene. MMP activity was sufficient to activate Prrx-1 expression in an axolotl skin culture. Furthermore, we found that such Prrx1activation was mediated by β3 integrin and focal adhesion kinase (FAK). Based on those findings, we demonstrated that these two activities could induce blastema-like cells without the influence of nerves in vivo.
Materials and methods

Animals and surgery for the induction of accessory limbs
Animals (size 8-12 cm long (nose to tail)) were obtained from personal breeders. They were housed in an aerated laboratory at 22°C. Their limbs, which had never previously been subjected to surgery, were used for ALM surgery. Surgical procedures were performed as described previously (Endo et al., 2004) .
Tissue culture
Axolotl skin was peeled from the forelimbs and/or hind limbs. To minimize fungal and bacterial contamination, the skin was washed several times with phosphate-buffered saline (PBS). Then, the skin was transferred to medium.
In the case of blastema cultures, middle-to-late bud blastemas from regenerating animals were harvested and cut into small pieces to enhance nutrient penetration. At least five pieces of blastemas were cultured per well. In case of skin cultures, upper arm/leg skin was harvested. The size of skin was about 5 × 5 mm. The culture medium comprised 70% L-15, 10% fetal bovine serum, 20% sterilized water and 0.2 mg/ml gentamicin. SU5402 (Calbiochem; 16.6 μM), FAK inhibitor (Sigma; 100 μM), FGF2 (R&D Systems; 0.1 μg/ml), FGF8 (Peprotech; 0.05 μg/ml) and collagenase (Wako; 034-10533) were added as supplements according to the individual experiment. Skin was cultured for 48 h and blastemas for 24 h at 28°C without a CO 2 supply.
RT-PCR, sequencing and quantitative RT-PCR (qPCR)
RNA (for use in RT-PCR analysis) was prepared using TriPure reagent (Roche). ALM samples were harvested at day 5. To collect blastema samples, the deviated nerve was first removed in order to eliminate nerve-associate cells. Then, blastemas were dissected out from the upper limbs. With respect to the D5 skin wound (control), isolated tissues contained the wound epidermis, regenerating dermis and peripheral skin (epidermis and dermis). Sequencing analysis was performed using a Roche 454 Sequencing system (Operon). Data were generated using MIRA software. Quantitative RT-PCR was performed using the ABI StepOne TM Real-Time PCR System. Data were analyzed using StepOne TM software version 2.1. Error bars indicate RQ max and RQ min . The following primers were used:
Ribosomal protein L19 forward, CATGGGCACTGGTAAGAGAAAAG; Ribosomal protein L19 reverse, GCGGCGCAAGATTCTCAT; Prrx-1 forward, CCCAGACGCCTTTGTAAGAG; Prrx-1 reverse, GGCGAAAC-TTTGCTCTTCGG; Collagenase forward, ACGAGGCAACAGGGAAAAC;
Collagenase reverse, -GTGCGTGTGTGTGTGTTTGA; Stromelysin-1/ 2a forward, GGAATGGGATTGGTGGAGAC; Stromelysin-1/2a reverse, GAGTGGTGGTTGTGGGTGTC; Stromelysin-1/2b forward, CCTTCCACTCCTGCTGCTAC; Stromelysin-1/2b reverse, GGTCAACG-CAGTCTTCTTCC; fgf-1 forward,GCGTGCATCTTGGACTTGTA; fgf-1 reverse, TACTCCCCGATGGAAAAGTG; fgf-2 forward, AGGAGC-GACTCCTGCATAAA; fgf-2 reverse, TGTCCAGTTCGTTTCAGTGC; fgf-10 forward, GGACTGCCCGTACAGTGTGATGG; fgf-10 reverse, GTCCTCGCTTGGGAGTTCCTTTC.
Immunohistochemistry and in situ hybridization
Immunohistochemistry and in situ hybridization were performed as described previously . In the case of type I Collagen andβ3Integrin staining, antigen retrieval was achieved through incubation with proteinase K (5 μg/ml). The following antibodies were used in immunohistochemical analyses: anti-type I Collagen (Sigma; diluted 1:200), anti-phospho-FGFR (Cell Signaling Tech.; 1:100), anti-phospho-FAK (Cell Signaling Tech.; 1:200), anti-β3 integrin (Cell Signaling Tech.; 1:200), Alexa 488-conjugated antirabbit IgG (Invitrogen; 1:500) and Alexa 596-conjuated anti-mouse IgG (Invitrogen; 1:500). Nuclei were stained with DAPI (Dojindo). Images were captured using an Olympus BX51 microscope system.
Western blotting
Whole-cell lysates were prepared using TriPure reagent (Roche) or lysis buffer (20 mM Tris-HCl (pH 8.0), 1 mM EDTA, 300 mM NaCl, 0.5% NP-40, 1 mM PMSF). Samples were separated by SDS-PAGE and blotted to nitrocellulose membranes (Bio-Rad). After blocking, membranes were incubated with the following antibodies: antiβ3Integrin (Cell Signaling Tech.; diluted 1:1,000), anti-phospho-FAK (Cell Signaling Tech.; 1:1,000) and anti-γ-tubulin (Sigma; 1:5000). Blots were washed six times in Tris-buffered saline containing 0.1% Tween-20 and were then incubated with secondary antibody. Bound antibody was detected using a chemiluminescent immunoblotting kit (Rockland). For each sample, the target protein signal was normalized to that for γ-tubulin in order to correct for differences in protein loading.
Bead preparation and grafting
Gelatin beads were prepared without CMC (carboxylmethyl cellurose) as described previously (Tabata et al., 1999) . Briefly, gelatin was dissolved in boiling water to give a 10% solution, which was then mixed with olive oil to form an oil-gelatin emulsion. This emulsion was washed with acetone and distilled water. Then, bead particles were treated overnight with 2 mM glutaraldehyde. The beads were further agitated in a 10 mM aqueous solution of glycine for at least 1 h to block the aldehyde groups of residual Glutaraldehyde molecules. The beads were finally washed with distilled water several times and stored at 4°C. Just before grafting, beads with 300-600 μm diameter were selected. They were used within a month of preparation.
FGF2 (R&D Systems; 300 ng/μl) and FGF8 (Peprotech, 200 ng/μl) were adsorbed to the gelatin beads through incubation at 4°C for at least 2 h. Control beads were treated with PBS. SU5402 (10 mM) and GM6001 (10 mM) were incubated with AG1-X2 beads (Bio-Rad). Wounds (2 mm × 2 mm) were made on the upper arms/legs (day 0). GM6001 soaked Beads were grafted underneath the wounds on days 2, 4, 6 and 8. An incision was created in a 2-5 mm proximal region of the wound. A tunnel to the wound was made by a forceps and then the beads were grafted by a tungsten needle. Samples were collected on day 10.
Induced blastemas by FGFs soaked beads were grafted into a cartilage regenerating region. This procedure was basically followed previous report (Satoh et al., 2010a) . Induced blastemas were dissected out by scissors. And the epithelium was removed mechanically by forceps. The bared mesenchymal tissue was labeled by Cell Tracker Green (Lonza). The blastema mesenchyme was cut into a small pieces and put into the labeling solution (5 μM) for 30 min at room temperature. Then the labeled tissues were rinsed by PBT at least five times and grafted. Sections were made 20 days after the surgery.
Results
Fgf signaling is activated in a regenerating blastema and is necessary for maintaining blastema marker genes
To identify genes active in the early phases of limb regeneration, we performed a sequence analysis using the Roche 454 GS-FLX sequencer on a 5-day-old (D5) ALM blastema and D5 simple skin wound, and obtained 374,904 and 394,743 reads, respectively (769,647 reads in total). All of these sequences were assembled by MIRA3 (version 3.0.0), and 36,081 different contigs were obtained. These contig sequences were subjected to BLASTX and BLASTN searches against human protein entries found in the NCBI NR database and Xenopus laevis entries found in the NCBI NR/NT database, respectively. They were also compared with Ambystoma ESTs using the BLASTN program. Sequence analysis revealed that fibroblast growth factor receptors (Fgfrs) were upregulated in D5 ALM blastema compared to those in D5 simple skin wound (Table 1) . The results were confirmed using quantitative RT-PCR (qPCR) (Fig. 1A, B) . qPCR revealed that Fgfr-1 and -2 were expressed at higher levels in D5 ALM blastema than in D5 simple skin wound (Fig. 1A, B ). This is consistent with the sequence results.
To clarify FGF sources, we focused on nerves, since nerves in a limb have been suggested to be a source of FGFs (Mullen et al., 1996; Poulin et al., 1993; Satoh et al., 2008b) . Dorsal root ganglia (DRG), which project axons into the limb, were collected and their Fgf expression pattern was investigated by RT-PCR (Fig. 1C) . Fgf-1 (acidic Fgf), Fgf-2 (basic Fgf),and Fgf-10 were found to be expressed in DRG. This suggests that the nerve deviating to the wound secretes FGFs in ALM. At the very beginning in ALM blastema, the deviated nerve is overlaid by WE during the early phases. To investigate whether WE received FGFs secreted from the nerves, phosphorylation of FGFRs was investigated. When the ligands (FGFs) bind to FGFRs, FGFRs are phosphorylated in order to transduce signals downstream. The basal layer of WE, where the nerve contacts the epithelium, showed an intense phosphorylated FGFR signal 3 days after ALM surgery ( Fig. 2A,  B ). Subsequently, a phosphorylated FGFR signal was detected in the mesenchyme and basal layer of WE (Fig. 2C, D) . To examine whether SU5402, a FGF-signaling inhibitor, could inhibit phosphorylation of FGFR, we investigated phosphorylated FGFR expression in the presence or absence of SU5402 ( Fig. 2E-I ). ALM blastemas were induced and SU5402-or PBS-soaked beads were added on day 4. Samples were fixed on day 5. Control beads (PBS-soaked) did not change phosphorylated FGFR expression levels, and levels were similar to those shown in Fig. 2C and D (Fig. 2E, F) . However, SU5402 treatment decreased phosphorylated FGFR expression levels ( Fig. 2G, H) . These results were confirmed by Western blot analysis (Fig. 2I ). Phosphorylated FGFR expression levels were almost undetectable in the SU5402-treated ALM blastema cells. These results suggest that nerves are the source of FGFs during the early phase of limb regeneration, and that WE and blastema mesenchyme receive FGFs from the nerves.
To examine the function of Fgf signaling in blastema maintenance, SU5402 was added to a D4 ALM blastema. The gene expression pattern was examined a day after beads grafting (D5 ALM blastema, Fig. 3 ). In the control (DMSO-soaked beads grafted limb), blastema marker genes-Prrx-1, a blastema mesenchymal marker gene, and Sp-9, an AEC marker gene-were not affected and were maintained in the ALM blastema mesenchyme and AEC, respectively (Fig. 3B, D) . In contrast, SU5402-soaked beads inhibited gene expression. Prrx-1 was downregulated, and only a faint signal was detected in a few cells (Fig. 3A,  arrows) . Furthermore, Sp-9 was downregulated (Fig. 3C) . We confirmed Prrx-1 regulation by Fgf signaling in the cultured blastema using qPCR (Fig. 4A) . Late bud blastema formed on amputated limbs were harvested, cut into two pieces, and cultured for 24 h. FGF2 and 8 (FGF2&8) supplement increased Prrx-1 expression compared with the control (Fig. 4A) , while SU5402 treatment decreased Prrx-1 expression. This is consistent with the in vivo experiment (Fig. 3A,   B) . A blastema, which stops growing, develops a collagen matrix (Endo et al., 2004; Satoh et al., 2008a) . The above gene expression data indicate that the blastema is not maintained properly and stops growing in the presence of SU5402. Hence, we investigated collagen deposition using immunohistochemistry in this blastema (Fig. 3E, F) . As expected, collagen was deposited in the SU5402-treated ALM blastema mesenchyme (Fig. 3E) , and the boundary between AEC and mesenchyme showed a collagen signal, indicating the development of basal lamina (arrowheads). In contrast, the growing ALM blastema did not show much collagen deposition (Fig. 3F , Endo et al., 2004; Satoh et al., 2008a) . This lack of collagen deposition indicated Fgf-signaling related to higher MMP activities. To test this possibility, we cultured regular blastemas with FGF2&8 supplement or SU5402, and then performed RT-PCR in order to test MMP genes (Fig. 4B) . Inhibition of Fgf signaling by SU5402 decreased the MMP gene expression levels (Collagenase, Stromelysin-1a, and -1b), whereas FGF2&8 supplements maintained MMP activity. This is consistent with the result that SU5402-treated ALM blastema showed higher collagen deposition. These results indicate that FGF signaling plays an important role in blastema maintenance.
Next, we investigated the function of Fgf signaling in Prrx-1 activation. The abovementioned data suggest that Fgf signaling is necessary for maintaining blastema cells that are already expressing Prrx-1. Dermal fibroblasts can become blastema cells during the early phase of limb regeneration (Hirata et al., 2010; Kragl et al., 2009; Muneoka et al., 1986) . We speculated that Fgf signaling had some functions in Prrx-1 activation in dermal fibroblasts. To examine this, axolotl limb skin, not blastema, was removed and cultured with FGF2&8 or SU5402 (Fig. 5A ). FGF2&8 application did not enhance Prrx-1 expression compared to that of the control, although SU5402 decreased its expression. This indicates that FGF2&8 did not function in Prrx-1 activation in our culture.
Collagenase treatment promoted Prrx-1 expression in vitro
The above data indicate that other candidates induce Prrx-1 before Fgf signaling acts to maintain the blastema. Our sequence analysis suggested MMPs as candidates, since MMP genes were more upregulated in the D5 ALM blastema than in the D5 simple skin wound (Table 1 ). In early limb regeneration, fibroblasts should be released from the attached matrix to form an undifferentiated blastema. Extracellular matrix ECM degradation by MMPs may be involved in the release of fibroblasts from ECM. As mentioned above, we surveyed our sequence database and found many contigs annotated as MMP genes. First, we confirmed sequence data by qPCR (Fig. 6A) . Based on this data, we selected three MMP genes (Collagenase, Stromelysin-1a,and -1b) from our database. All three MMP genes were upregulated in the D5 ALM blastema more consistently than in the D5 ALM wound (Fig. 6A) . To investigate MMP function in Prrx-1 activation, a piece of skin was cultured with collagenase ( Fig. 5B) . After culturing for 48 h, Prrx-1 expression was observed to be more upregulated than in the control. Additional FGF2&8 supplement application did not enhance the effect of collagenase on Prrx-1 activation. This indicates that collagen degradation plays a role in blastema cell induction. We examined Prrx-1 expression in a regular limb blastema and compared its expression to that in intact skin. Prrx-1 expression level in the regular blastema was approximately 8 times more than that in intact skin (Fig. 5C ). However, its expression level in our tissue culture experiment was approximately 2.5 times greater in collagenase-treated skin than in the control (Fig. 5B ). This may be because of suboptimal culture conditions for axolotl cells, since the ideal cultivation conditions have not been established. Alternatively, ECM may not be degraded sufficiently in vitro to induce a fully Prrx-1 activated state.
FAK phosphorylation and β3 integrin expression pattern are correlated with ECM degradation
In order to clarify how ECM degradation transduces a cell to promote Prrx-1 expression, we focused on β3integrin and FAK. Integrins are links between cells and ECM (Hynes, 2009) , and FAK is autophosphorylated (pFAK) after integrin activation and mediates the integrin signal into a cell. We first investigated β3 integrin and FAK phosphorylation in cultured skin (Fig. 7A, control) . β3 integrin was detected in cultured normal skin, but not pFAK. To explore whether collagen degradation activated β3 integrin and pFAK expression, a piece of axolotl skin was cultured with collagenase. Skin cultured with collagenase showed activation of β3 integrin and pFAK expression (Fig. 7A ). This was also observed when skin was cultured with FGF2&8 supplement and collagenase, although the increase in β3 integrin expression was slightly higher. When a chemical inhibitor of FAK phosphorylation was added to the culture media, both β3 integrin and pFAK expression levels were decreased (Fig. 7A ). This suggests that there is a positive feedback loop from pFAK to β3 integrin. We also investigated the in vivo expression pattern. Intact skin possessed some amount of β3 integrin (Fig. 7B1) and pFAK (Fig. 7B2) . In contrast, the regenerating ALM blastema exhibited much higher immunohistochemical signals for both (Fig. 7B3, B4 ). The expression pattern is consistent with Western blot analysis (Fig. 7A) . Next we confirmed that FAK signaling plays a role in Prrx-1 activation. FAK inhibitor was added to the skin tissue cultured with FGF2&8 and collagenase (Fig. 7C) . Compared with the results shown in Fig. 5B , the FAK inhibitor successfully suppressed Prrx-1 activation by collagenase. These results indicate that β3 integrin activation and FAK phosphorylation induced by ECM degradation promote Prrx-1 expression in an axolotl skin.
FGF-soaked gelatin beads can induce a blastema-like in the absence of a nerve
The above data clearly indicate that MMP activity and Fgf signaling plays an important role in Prrx-1 regulation. Therefore, we attempted to introduce these two in a limb to induce an ALM blastema. Direct collagenase application, however, resulted in limb deformity because most of the structural components, such as the dermis, consist of collagens, and collagenase treatment disrupted these structural collagens. Therefore, we decided to use a different method. We had found that bead grafting alone elevated MMP activities in vivo (Fig. 6B) . PBS-soaked FGF2&8 supplemented with collagenase treatment could not elevate Prrx-1 expression as compared with simple collagenase-treated samples. ***P b 0.01 (C) The Prrx-1 gene expression was compared in the blastema and intact skin. Blastema exhibited much higher Prrx-1 expression levels compared to the Prrx-1 activation by collagenase application (Fig. 5B) . beads were inserted under a simple skin wound at D4. Samples were harvested at D5 in order to test the MMP gene expressions. Three MMP genes were compared in D5 bead-grafted and simple wounds. All three MMPs were upregulated in the bead-grafted wound (Fig. 6B) . Histological observation showed that leucocytes, which exhibit higher MMP activity, gathered around the grafted beads. This gathering of leucocytes may result in higher MMP activity. Bead grafting can, therefore, act as a substitute for MMP overexpression. Furthermore, we made another improvement to this method. General beads, which are usually used in developmental biological experiments, release proteins and/or chemicals relatively rapidly. Growing a blastema takes a relatively long time, and hence, release of FGF2&8 supplement, which is applied to the wound using beads, must be sustained for a long time. To maintain FGF2&8 release for longer periods, we prepared gelatin beads, as described in the Materials and Methods. We grafted FGF2&8-soaked gelatin beads instead of general beads. The grafted control PBS-soaked beads induced "bump" formation in a few cases (Table 2) ; however, the majority showed none (Table 2, Fig. 8A ). By contrast, grafting with FGF2&8-soaked beads resulted in a higher rate of bump induction ( Table 2 ). The induced bump was similar in appearance to an ALM blastema (Fig. 8B) . To examine this further, we sectioned the induced bump. Histological analysis revealed that fibroblastic cells had accumulated on the control side (PBS-soaked beads grafted wound), which suggested that the wound was beginning to heal (Fig. 8C) . Because skin wounding without nerve deviation results in healing and collagen reorganization (Satoh et al., 2008a) , we investigated collagen deposition (Fig. 8E) . Reorganizing collagens were easily visualized (Fig. 8E) . In contrast, FGF2&8-soaked beads grafted into the skin wound induced relatively compact mononuclear cells, which looked like typical blastema cells (Fig. 8D) . Small round cells were observed around the beads, which suppressed collagen deposition, similar to a regular growing blastema (Fig. 8F) . These results suggested that the grafted FGF2&8 beads induced a blastema-like cell. We investigated whether the induced bump was a blastema using molecular marker genes. Prrx-1 and Sp-9 were not detectable on the control side (Fig. 8G,  I ); however, they were clearly expressed in the induced bump (Fig. 8H,  J) . Furthermore, β3 integrin expression and pFAK localization patterns were similar to those of an ALM blastema (Fig. 7B3-B6 ). These data indicate that the induced bump has ALM blastema features. We further confirmed presence of MMP activity in the bump induction. We applied an MMP inhibitor, GM6001, to an FGF2&8 bead-grafted wound (Table 2, Fig. 9 ). In most cases, bump formation was inhibited (Table 2) ; however, in some, growth was detected (Fig. 9) and we further investigated this structure. Sections of the structure showed that extensional epithelial growth was present (Fig. 9A, B) , but in the mesenchyme, no extension or invasion was observed. We did not consider this a "bump" since collagen deposition could be seen in the mesenchyme (Fig. 9C) and Prrx-1 expression was rarely detected (Fig. 9D) . In a few cases, we observed weak Prrx-1 expression in the bump. Therefore, we determined growth as bump formation (Fig. 9E,  F) . GM6001 was not retained on the beads for an extended period of time; therefore, certain periods were "inhibitor free" causing low rate of bump induction. Finally, we examined the differentiation capability of the induced bump cells by FGF2&8 bead grafting (Fig. 10) . It has been considered that blastema cells derived from dermal tissues are multipotent. They can redifferentiate into multiple tissue lineages within a connective tissue lineage, such as a cartilage cell, during limb regeneration (Hirata et al., 2010; Kragl et al., 2009; Muneoka et al., 1986) . We isolated the induced bump mesenchyme and labeled it with green fluorescent Dye. Next, the labeled bump mesenchyme was grafted into a region of regenerating cartilage (Fig. 10A ). This assay was previously reported as the bone excision model (Satoh et al., 2010a) . The previous report showed that regular blastema cells and ALM blastema cells can participate into cartilage regeneration, although differentiated dermal fibroblasts cannot. If the induced bump cells possess such ALM blastema/regular blastema features, the induced bump cells should participate into cartilage regeneration. Sections showed that the amputated bone was bridged by cartilage cells, which were stained on Alcian blue staining (Fig. 10B, C) . The cartilage-forming region, where type II collagen was present, contained green-labeled cells (Fig. 10D, E) . Since the green fluorescent dye labeling the cellular membrane and type II collagen is an ECM protein, the red and green signal did not overlap, but it was obvious that labeled cells participated in cartilage formation. This result clearly indicates participation of the induced bump cells in cartilage regeneration and differentiation into cartilaginous cells. We further investigated the ability of the induced bump cells by FGF2&8 bead grafting (Fig. 11) . Whether the induced bump could participate in regular limb regeneration was examined. Bump formation was induced by FGF2&8 bead grafting in a GFP transgenic axolotl. The GFP bump mesenchyme was transplanted into a regular blastema at the medium bud stage (Fig. 11A-C) . After 10 days, GFP positive cells had expanded distally (Fig. 11B, C) . The blastema was fixed and sectioned to investigate cellular contributions (Fig. 11D-F) . Histological analysis revealed that cartilage had already developed in the regenerate (Fig. 11D) . Furthermore, immunohistochemical analysis revealed that GFP-positive cells could be seen in the cartilage region, where type II collagen was expressed (Fig. 11E) . This is consistent with the results shown in Fig. 10 . In the distal region where most of the blastema cells were undifferentiated, GFP-positive cells were detectable, although type II collagen had not yet developed (Fig. 11F) . GFP-positive cells could be seen from the proximal to the distal region of the regenerate. These results indicate that the induced bump cells can participate in regular limb regeneration. Considering these results together with gene expression patterns, it is suggested that the induced bump is an equivalent structure to an ALM blastema and a regular blastema.
Discussion
We demonstrated that MMP activity and application of FGF2&8 supplement to a lateral skin wound were sufficient to induce a bump cell, which appears to be a blastema cell. The bump induction is independent from nerves in our experiment. In other words, bump induction was completed in an aneurogenic state. Since the neurotrophic factor(s) controlling limb regeneration have not been elucidated, limb regeneration under aneurogenic conditions has long been attempted. Our study provides an understanding of the involvement of neurotrophic factors and fibroblast activation in limb regeneration in urodele amphibians.
Neurogenic regulation during the early phase of limb regeneration
In ALM, a nerve participates in limb regeneration from the very beginning. Three days after amputation, axons can be observed within the overlying epithelium. The nerve secretes FGFs ( Fig. 1C ; Mullen et al., 1996; Poulin and Chiu, 1995; Satoh et al., 2008b) , and the overlying epithelium receives them from the nerve in ALM (Fig. 2; Poulin et al., 1993; Satoh et al., 2008b) . The primary target of FGF secreted from the nerve would be the overlying epithelium. Furthermore, Sp-9 is initiated by nerve-secreted FGF (Satoh et al., 2008b) . In this study, we reported the regulation of Fgfr genes in an ALM blastema and a simple skin wound (Fig. 1A, B) ; the expression of these genes was previously reported in a regular limb blastema (D'Jamoos et al., 1998; Poulin et al., 1993) . Fgfr-1 is dominantly expressed in the blastema mesenchyme, and Fgfr-2 is mainly regulated by AEC in the blastema. Both genes are upregulated in the D5 ALM blastema (Fig. 1A, B) . Given the Fgfrs expression pattern and knowledge in limb development, presence of an Fgf-positive feedback loop is suggested. In limb development in higher vertebrates, the FGF feedback loop functions to grow the limb bud distally (Martin, 1998) . Limb regeneration is similar to limb development; therefore, the Fgf feedback loop in axolotl limb regeneration should play a role in blastema growth. Nerves trigger the formation of the Fgf feedback loop because there is no initial blastema mesenchyme at the very beginning of ALM. During regeneration following limb amputation, dermal fibroblasts start to migrate, dermal fibroblasts start to migrate approximately 5 days after amputation (Gardiner et al., 1986) , therefore, nerve-secreted FGFs are most likely to induce AEC formation and then AEC and/or nerves induce blastema mesenchyme, secreting FGFs back to the AEC.
ECM reconstitution in wound healing and limb regeneration
The importance of ECM regulation has long been known. In our sequence data, upregulation of the MMP genes was observed. Dermal fibroblasts, which produce a collagen matrix to maintain skin structure, are a major source of blastema cells . The dermis cells are laid in a collagen matrix, and some are embedded in a relatively thick collagen layer in normal skin. In contrast, a blastema shows less ECM structures because there is higher MMP activity (Fig. 6A , Stevenson et al., 2006; Vinarsky et al., 2005; Yang and Bryant, 1994; Yang et al., 1999) , and observation with an electron microscope showed that even the basal lamina between the blastema mesenchyme and AEC is absent (Bryant et al., 1971) . Basal lamina development appears to be related to mesenchymal differentiation. In the differentiating blastema, the basal lamina develops and dermis is formed in the proximal region, where cellular differentiation occurs (Satoh et al., 2008a) . In case of wound healing, dermis differentiation starts from a relatively early phase as compared with limb regeneration (Endo et al., 2004; Satoh et al., 2008a) . Collagen (dermis) regeneration and reorganization, including basal lamina reformation, begin from the early phase of wound healing. The differentiating dermal fibroblasts express AmTwist and type I Collagen deposits can be seen in the same region. However, when a nerve is deviated and AEC is induced, AmTwist expression and collagen synthesis are inhibited (Satoh et al., 2008a) . Given that AEC, the nerve, and the blastema mesenchyme form a positive feedback loop of FGFs, higher MMP expressions should be maintained by the Fgf feedback loop in a blastema. This is consistent with the results shown in Fig. 4B . Other ECM proteins have also been described (Klatt et al., 1992; Nace and Tassava, 1995; Onda et al., 1991; Stocum, 2004; Wei et al., 1995; Yang et al., 1992) . Tenascin-C (TN-C) is one of the earliest and the most abundant blastema marker genes in amphibian limb regeneration, and accelerates cell migration (Onda et al., 1990 (Onda et al., , 1991 . Fibroblasts around an amputation or wound site should migrate toward the site where the blastema grows. Interestingly, TN-C is regulated by Prrx-1 in higher vertebrates (Ihida-Stansbury et al., 2004 , 2005 . Therefore, it is reasonable that TN-C is positively regulated in the blastema. Fibronectin is also upregulated in the blastema, and is synthesized in both AEC and mesenchymal cells (Gulati et al., 1983; Nace and Tassava, 1995; Repesh et al., 1982) . Furthermore, in higher vertebrates, cell migration is supported by Fibronectin during wound healing (Briggs, 2005) . Toward the end of limb regeneration, TN-C and Fibronectin expression decreases and fibroblasts seem to differentiate into a mature state (Nace and Tassava, 1995; Onda et al., 1991) . To maintain appropriate conditions, the ECM is actively regulated by enzymes through synthesis and degradation in limb regeneration.
Activation of dermal fibroblasts
Dermal tissue can generate multipotent blastema cells. In this study, we showed that Prrx-1, a blastema marker gene, was upregulated in a skin tissue by collagenase treatment. In amphibian limb regeneration, Prrx-1 expression was first reported in the African clawed frog (X. laevis),an anuran amphibian, and was found to be upregulated in the regenerating blastema (Suzuki et al., 2005 (Suzuki et al., , 2007 . The similar Prrx-1activation could be detectable in axolotl, a urodele amphibian . In both amphibians, Prrx-1 expression could not be detected in completely differentiated dermal fibroblasts; therefore, Prrx-1 would be proper to use as one of blastema marker genes. We first speculated that FGFs secreted from a nerve activated Prrx-1 gene expression to induce formation of a blastema. However, Prrx-1 was not induced by FGF2&8 supplement (Fig. 5A) . This is consistent with the observation that nerve deviation under mature skin does not induce formation of a blastema (unpublished data). Because FGFs seems not to be an inducer of limb regeneration, we next focused on MMPs. Significant differences in MMPs expression could be detected in our sequence database and this was confirmed by qPCR (Fig. 6A, Table 1 ). It was reported that initial MMPs activities are not nerve dependent although it is considered that maintenance of MMP genes was nerve dependent (Yang et al., 1999; Yang and Bryant, 1994) . In fact, the migrating epidermis starts expressing MMP-9 in limb regeneration within 2 h (Ferris et al., 2010; Satoh et al., 2008b) , and many hematopoietic cells, such as microphages and neutrophils, exhibit high MMP activity (Vihinen and Kahari, 2002) . Therefore, MMP activation occurs independently of the presence of a nerve in the early phases. In later phases, MMP expression appears to be related to the presence of a nerve. As shown in Fig. 6A , MMP activity is downregulated in wounds and maintained in blastemas. In the previous study, collagen deposition was detected within 10 days of simple skin wounding, indicating low MMP activity (Satoh et al., 2008a) . In contrast, nerve deviation to a wound inhibits such collagen deposition, suggesting that nerves support MMP activity (Satoh et al., 2008a) . As mentioned above, Fgfs are likely to be neurotrophic factors. We demonstrated that Fgfs maintain collagenase and stromelysins in ALM blastema cells (Fig. 4B) . We still do not know whether nerve-secreted or AEC-produced Fgfs support MMP activity, but it is unsurprising that the blastema is rich in Fgfs. Such an Fgf-rich environment maintains high MMP activity in the blastema. MMPs target and subsequently degrade collagens in tissues. ECM degradation can change TN-C gene expression, which is regulated by Prrx-1 (Jones et al., 1999 (Jones et al., , 2001 McKean et al., 2003) . In vascular cells, Prrx-1 is potentially regulated by ECM degradation (Jones et al., 2001) . Cells plated on native collagen suppress the Prrx-1 gene, while cells plated on heat-denatured collagen activate the Prrx-1 gene (Jones et al., 2001) . Therefore, it is unsurprising that axolotl fibroblasts exhibit the same regulatory systems. We also investigated the intracellular regulatory mechanism (Fig. 7) . The ALM blastema, which exhibits high MMP activity, had relatively high levels of pFAK. FAK can act as a sensor of ECM modification (Wederell and de Iongh, 2006) . Integrins are located upstream of pFAK, and β1 integrin is downregulated in amphibian regeneration blastemas (Tsonis et al., 1997) and β3 integrin is upregulated in the ALM blastemas, as shown in Fig. 7B . This integrin regulation is consistent with our knowledge of vascular cells (Jones et al., 1999) . In axolotls, it is likely that intact fibroblasts express β1 integrin to maintain their attachment to ECM, and activated fibroblasts change β1 integrin to β3 integrin to transduce signals to FAK. It is still not known what these integrins bind to, but it is likely that natural collagens and collagens degraded by MMPs are their targets. Collagenase treatment, which would result in collagen degradation, somehow upregulated Prrx-1 in our tissue culture experiment (Fig. 5B) . However, the activated Prrx-1 expression level was low compared with its expression in the blastema (Fig. 5B, C) . We believe that continuous FGF input is necessary to increase Prrx-1 expression. Unfortunately, we cannot examine our hypothesis in vitro because the appropriate conditions for culturing axolotl cells are not known and is difficult to maintain axolotl cells in a highly proliferative state since most cells undergo senescence within several days and long-term cultivation is difficult. SU5402 applied to ALM blastema decreased Prrx-1 expression (Fig. 4A) . Therefore, it is suggested that Fgf signaling maintains Prrx-1 expression in coordination with MMP activity. It is still not known whether Fgf signaling controls Prrx-1 expression through a modification of MMPsor a different signaling cascade is involved. Fibroblasts are activated by ECM modifications and Fgf is active during the early phases of limb regeneration. Prrx-1-positive cells derived from dermal fibroblasts may acquire multipotency during this activation process. It is still not clear how fibroblasts reprogram their cellular information, such as their positional value; however, the activation process is now partially unveiled.
Bump induction by FGF2&8-soaked gelatin beads in an aneurogenic environment
The neurotrophic factor in amphibian limb regeneration has long been a mystery. In this study, we succeeded in inducing a bump, which has similar features to a regeneration blastema, in an aneurogenic environment. Prrx-1 and Sp-9 expression patterns in the bump induced by FGF-soaked beads were consistent with those in regular and ALM blastemas ( Fig. 8G-J , Satoh et al., 2008b Satoh et al., , 2007 . Moreover, the bump cells induced by FGF2&8 bead grafting could participate in cartilage regeneration and regular limb regeneration (Figs. 10 and 11 ). These observations suggest that the induced bump is equivalent to a blastema. We still do not know whether FGF2&8 acts as a nerve factor in limb regeneration; however, it is likely that FGF2 is a nerve factor because Fgf-2 is expressed in nerves ( Fig. 1C ; Mullen et al., 1996) . Fgf-8 is more commonly regarded as an AER/AEC factor rather than as a neural factor (Christen and Slack, 1997; Endo et al., 2000; Han et al., 2001; Mahmood et al., 1995) . However, it was recently reported that Fgf-8 was expressed in DRG in mouse embryos (Tanaka et al., 2001) . It is, therefore, possible that FGF8works as a neural factor. The Fgf-8 expression pattern has been reported in a regenerating amphibian blastema Han et al., 2001) . The basal layer of the distal blastema epithelium expresses Fgf-8; therefore, FGF2 and FGF8 are abundantly supplied from a nerve and/or AEC. It is clear that many factors interact in a complex manner in the early phases of limb regeneration; therefore, nerve function, AEC induction, and blastema cell induction should be considered together.
The bump cells induced FGF2&8 bead grafting could transdifferentiate. As reported previously, when dermal fibroblasts are dissociated (ECM digestion) and grafted into a cartilage regenerating region, those dermal fibroblasts remain fibroblastic and do not differentiate into cartilage cells (Satoh et al., 2010a) . This indicates that ECM degradation alone cannot induce blastema cells. Further regulation would be necessary for blastema cell induction. ECM digestion could activate dermal fibroblasts to express blastema marker gene (Fig. 5B) . So, ECM digestion would be sufficient to activate fibroblasts but insufficient to induce blastema cells. We speculate that activated fibroblasts need to be exposed to an FGF-rich field created by nerves and AEC or other factors in order to become blastema cell. Neural factors such as nAG, substance P, and glial growth factor may be involved in limb regeneration (Brockes and Kintner, 1986; Globus et al., 1983; Kumar et al., 2007) . These factors may be involved in an induction of blastema cells.
